The story of Viagra presents a intricate picture for investors. While the initial launch generated massive gains, the end of its intellectual property protection opened the door to cheaper versions, dramatically https://prbookmarkingwebsites.com/story29027348/the-copyright-and-big-pharma-a-risky-opportunity